© 2020 MJH Life Sciences and Endocrinology Network. All rights reserved.
© 2020 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
September 30, 2020
An analysis of nearly 300k offspring suggests those exposed to diabetes in the womb were at an increased risk of cardiovascular disease events and risk factors in young adulthood.
September 29, 2020
An analysis of data from the Women's Health Initiative is offering clinicians a look into the impact of menopause symptoms on cardiovascular health in older women.
September 28, 2020
An associate professor from University of Toronto discusses whose responsibility it is to prescribe SGLT2 inhibitors to patients.
September 18, 2020
New research suggests children treated with high-doses of oral glucocorticoids could be at a greater risk of diabetes, hypertension, and venous thromboembolism.
September 17, 2020
Data from the WHI indicates adverse pregnancy outcomes were associated with increased risk of ASCVD later in life.
September 11, 2020
An interview examining the use of coronary artery calcium scores for predicting CV events and stroke risk in real-world settings.
September 08, 2020
Paul Thompson, MD, offers perspective on the effects of tamoxifen on triglyceride levels.
September 06, 2020
Melissa Young, MD, offers perspective on the push to create cardiometabolic fellowships versus making endocrinology a more desirable field.
September 05, 2020
An analysis from ESC Congress 2020 is shedding further light on the effects of dulaglutide in patients with and without background metformin use.
September 03, 2020
An ESC Congress 2020 study details the predictive value of galectin-3 levels for predicting risk of cardiovascular events in patients with type 2 diabetes
August 31, 2020
Analysis of the UK Biobank cohort details associations between increased HbA1c levels and risk of myocardial infarction in patients regardless of sex.
August 27, 2020
A look at nationwide data from an 11-year period gives physicians a greater understanding of predictors, trends, and outcomes associated with stroke in hypertensive disorders of pregnancy.
August 26, 2020
New data from a pair of New Orleans-based hospitals suggests metabolic syndrome in Black patients with COVID-19 was associated with increased mortality.
August 25, 2020
Using data from a group of RCTs, investigators determined semaglutide was associated with greater reductions in HbA1c and weight loss than empagliflozin.
August 19, 2020
New research is shedding light on the association between a history of hypertensive disorder of pregnancy and risk of menopausal symptoms later in life.
August 13, 2020
An analysis of data from the UK and Canada has found no significant increase in below-knee amputations with SGLT2 inhibitor use versus DPP-4 inhibitor use.
August 06, 2020
Data from a prospective cohort study in Europe indicates increased antibiotic use and LPS activity levels were tied to increased incidence of coronary heart disease events.
Having 3 or more pregnancies, a shorter reproductive life span, or early age at menopause onset were linked to increased risk of CAD in a recent study.
August 04, 2020
An analysis of more than 60k women suggests those with polycystic ovary syndrome were 19% more likely to develop cardiovascular disease.
August 02, 2020
A systematic review and meta-analysis is detailing the risks of new-onset and recurrent heart failure, separately, in patients with diabetes mellitus.